By using this site, you agree to the Privacy Policy and Terms of Use.

Notification Show More

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel

Search

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
News
Technology
Travel

Follow US

Tag: (orelabrutinib)

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…

15/12/2025

InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore

InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore

BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…

08/09/2025

- Advertisement -

- Advertisement -

- Advertisement -

Categories

Automobile
Entertainment
E-Sports
Food
Health
Technology
LifeStyle
Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.

Quick Link

Top Categories

Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

I have read and agree to the terms & conditions

Leave this field empty if you’re human:

Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions

Leave this field empty if you're human:

Zero spam, Unsubscribe at any time.

Welcome Back!

Sign in to your account

Username or Email Address

Password

Remember me

Lost your password?